Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s):  XRTX

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance... see more

TSXV:XRTX - Post Discussion

XORTX Therapeutics Inc > LOVE THIS COMPANY............TIME TO BUY MORE
View:
Post by Anklebiter42 on Sep 28, 2021 10:28am

LOVE THIS COMPANY............TIME TO BUY MORE

What a great company. The CEO is executing his plan according to a schedule that was forecasted years ago. Institutional Investors are taking huge positions. Spaceblab, Richnomore, gflap and moneythinner1 will all lose their shirts......... LIFE IS GOOD!
Comment by Richmond on Sep 28, 2021 2:08pm
Please don't fool the investors or new shareholders to be, LOL...You can BUY Xortex all the way DOWN to .50c where it did the 1:11.70 RollBack ....It goes down daily. NOTHING TO PUMP HERE. INVESTORS ARE NOT STUPID....When is XORTEX going to LIST on NASDAQ????????????????!!!!!!!@@@!!!!!!!!!!!!!LOL...last laugh....
Comment by Moonrunner on Sep 28, 2021 2:12pm
They will go onto the NASDAQ On October 7th
Comment by Richmond on Sep 28, 2021 2:54pm
At what Share Price? By October7th, XORTEXwill be under $5.00, most likely $3.00....Then, WHAT???? Anither Rollback???3:1....... We have roughly 10M shares but will go to Nasdaqwith 3M LOL... .............
Comment by Anklebiter42 on Sep 28, 2021 6:24pm
Richnomore. I will not attempt to explain Macroeconomic forces to a man that is unable to spell XORTX correctly. Everything is down over the last couple weeks. Thats when smart investors buy. Let me guess......... your not buying. Haha.  You are right about one thing.... "Investor are not stupid." You just need to realize that you and rest of the clowns (spaceblab, gflap and ...more  
Comment by Richmond on Sep 29, 2021 10:47am
Hey, smartypants, anklebiter.. Now that you know so much, could you care to inform us 1....at what price is XORTEX listing on Nasdaq? 2.... if the Markets were badly down for the past few weeks, then isn't XORTEX"s Management using their brain and not Rollback till the day of listing, to avoid the big dinward swings? Investigate and Answer!!!!!!.. Stay on the topic. I didn't call you ...more  
Comment by Anklebiter42 on Sep 29, 2021 4:29pm
Hey Richmond.  1. How would I know what price Xortx will list on the Nasdaq at? That information is maintained in the C Suite of a company. It would be unethical and illegal for any of us to know that. You have been brainwashed by Spacelab too much. There is no secret Xortx Cabel with Robert McWhirter, BNN and the CEO. Do Instituational Investors have greater access to company Executives ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities